Wealthcare Advisory Partners’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
BCC
MFP
HCL
QF
Wealthcare Advisory Partners's ATEX Position: Q2 2021 in Review
Wealthcare Advisory Partners sold out of Anterix (ATEX) in Q2 2021, closing a stake of 130 shares — an estimated $6K sold.
Wealthcare Advisory Partners first reported a position in ATEX in Q3 2018 and held it in 8 quarters. The position peaked at $6K in Q1 2021. 107 funds tracked by Wall St. Rank hold ATEX as of Q2 2021.
- Wealthcare Advisory Partners reported no remaining Anterix position as of Q2 2021 after selling out during the quarter.
- Wealthcare Advisory Partners sold 130 Anterix shares in Q2 2021, an estimated $6K.
- Wealthcare Advisory Partners first reported a position in Anterix in Q3 2018 and held it in 8 quarters.
- Wealthcare Advisory Partners's Anterix position peaked at $6K in Q1 2021.
- 107 funds tracked by Wall St. Rank held Anterix as of Q2 2021.
Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.